News From Law.com
BioXcel Therapeutics Inc. faces a shareholder derivative lawsuit, saying officials breached their fiduciary duties by failing to follow proper protocols in clinical trials for a neurological medicine, and the principal investigator allegedly fabricated email communications.
Biotech & Pharmaceuticals
November 29, 2023, 5:35 PM